Join to View Full Profile
160 E 34th StNew York, NY 10016
Phone+1 212-731-5196
Dr. Raphael is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Bruce Raphael, MD, is an oncology specialist based in New York, NY, with a subspecialty in hematologic oncology. He completed fellowships in hematology and medical oncology at Memorial Sloan Kettering Cancer Center and NYU Grossman School of Medicine. Dr. Raphael is a Clinical Professor of Medicine at New York University School of Medicine since 2000. He is experienced in conditions such as amyloidosis, hematologic oncology, cold agglutinin disease, thrombocytopenia, and myelodysplasia. His publications include research on T cell exhaustion in Hodgkin's lymphoma and SARS-CoV-2 vaccination in lymphoma patients. He has been involved in several clinical trials for blood disorders and has received multiple recognitions, including America's Top Doctors and Top Doctors: New York Metro Area by Castle Connolly.
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1978 - 1980
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1977 - 1978
Jewish General Hospital- Mcgill University1975 - 1977
McGill University Faculty of MedicineClass of 1975
Certifications & Licensure
NY State Medical License 1977 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2005-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- New York Magazine: Top Doctors Castle Connolly, 2002, 2004-2014
- Join now to see all
Clinical Trials
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial Start of enrollment: 2004 Sep 21
- Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma Start of enrollment: 2011 Feb 09
Publications & Presentations
PubMed
- terraFlow, a high-parameter analysis tool, reveals T cell exhaustion and dysfunctional cytokine production in classical Hodgkin's lymphoma.Daniel Freeman, Catherine Diefenbach, Linda Lam, Tri Le, Jason Alexandre
Cell Reports. 2024-08-27 - 18 citationsImpaired Humoral Immunity to SARS-CoV-2 Vaccination in Non-Hodgkin Lymphoma and CLL PatientsCatherine Diefenbach, Jessica Caro, Akiko Koide, Michael L. Grossbard, Judith D. Goldberg
Medrxiv. 2021-06-03 - 20 citationsMicrobial dysbiosis is associated with aggressive histology and adverse clinical outcome in B-cell non-Hodgkin lymphomaCatherine Diefenbach, Brandilyn A. Peters, Huilin Li, Bruce Raphael, Tibor Moskovits
Blood Advances. 2021-03-09
Professional Memberships
- Member
- Member
- Eastern Cooperative Oncology GroupMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
